sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÑõÓÕµ¼ÊÓÍøÄ¤ÐÂÉúѪ¹Ü
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > ÑõÓÕµ¼ÊÓÍøÄ¤ÐÂÉúѪ¹Ü

ǰÑÔ

ÄêËêÏà¹ØÐԻư߱äÐÔ(age related macular dege­neralion, AMD)ÊÇ65ËêÒÔÉÏÍíÄêÈËÖÂäµÄÖ÷ÒªÔµ¹ÊÔ­ÓÉ¡£AMD·ÖΪÎÞÐÂÉúѪ¹ÜÌìÉúµÄ¸ÉÐÔÒÔ¼°ÐÂÉúѪ¹ÜÌìÉúµÄʪÐÔÌåÏÖ¡£ÊªÐÔAMD»¼Õß±¬·¢CNVÊǵ¼ÖÂÊÓÁ¦ËðʧµÄ×î³£¼ûÒòËØ¡£±¾Õ½«ÏÈÈÝCNVµÄÔìÄ£ÒªÁì¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

ÑõÓÕµ¼ÊÓÍøÄ¤ÐÂÉúѪ¹Ü£¬²¡ÀíÐÔµÄÐÂÉúѪ¹ÜÐγɰéÓдÓÊÓÍøÄ¤ÅÀÐе½²£Á§ÌåÒì³£µÄѪ¹ÜÑ¿¡£ÕâÖÖÐÂÉúѪ¹ÜÑ¿µ¼ÖÂÐí¶à²¢·¢Ö¢£¬ÈçѪ½¬ÉøÂ©¡¢³öѪ£¬²¢ÔÚijЩÇéÐÎÏ£¬ÒýÆðÇ£À­ÐÔÊÓÍøÄ¤ÍÑÀë»òÖÂä¡£ÔÚ¸ßÑõ̻¶µÄµÚÒ»¸ö½×¶Î£¨³öÉúºó7~12Ì죩£¬ÊÓÍøÄ¤Ñª¹ÜËõ¶ÌÒÔµ÷ÀíÊÓÍøÄ¤ÖеÄÑõ·Öѹ£¬Í¬Ê±Î»ÓÚÖÐÐÄÊÓÍøÄ¤ÇøµÄ²»¿ÉÊìëϸѪ¹ÜÍË»¯µ¼ÖÂÖÐÐÄÇøÑª¹Ü±ÕÈû¡£ÓÉÓÚ¸ßÑõ̻¶ºÍÐÄÀíÐԵıÊֱѪ¹ÜÑ¿´Ódz²ãëϸѪ¹ÜÍøÏòÉî²ãÉú³¤µÄʱÏàÖØµþ£¬´Ó¶øµ¼ÖÂÊÓÍøÄ¤Éî²ãëϸѪ¹ÜÍøÐγÉÏÔ×ŵÄÑÓ³Ù¡£µÚ¶þ¸ö½×¶Î£¬ÔÚ³öÉúºó12Ìì»Øµ½Õý³£¿ÕÆøÇéÐÎÖÐÖ®ºó£¬Ñª¹Ü±ÕÈûÇø×îÏÈȱÑõ£¬Ð¡ÊóµÄÊÓÍøÄ¤Ñª¹Ü±ÕÈûÇøÎÞѪ¹ÜºÍ²¡ÀíÐÔÐÂÉúѪ¹ÜµÄÌìÉú¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

½«1ÖÜСÊóÓëËüÃǵÄĸÊóÖÃÓÚÑõŨ¶ÈΪ75£¥±2£¥µÄ¶¯ÎïÑõ²ÕÖÐÎ¹Ñø5Ìì¡£Ñõ²ÕÄÚÑõÁ÷Á¿¿ØÖÆÔÚ0.5~0.6L/min£¬ÅÅÆøÁ÷Á¿¾Þϸ¿É×ÔÐе÷Àí£¬°ü¹ÜÑõÆøÑ­»·Á÷¶¯£¬²¢ÇÒŨ¶ÈÎȹÌÔÚ75£¥×óÓÒ£¬±È¼°Ñõ²ÕÖÐÑõÆøÅ¨¶ÈÎȹ̺ó£¬Ã¿¸ô4СʱÓÃÊý×Ö²âÑõÒǼà²âÑõ²ÕÄÚÑõÆøÅ¨¶È£¬°ü¹ÜÆøÌåµÄÁ÷ÈëºÍÁ÷³öƽºâ¡£Ñõ²ÕÄÚѹÁ¦Ò»¶¨Òª¼á³ÖΪ³£Ñ¹»òÕß¿¿½ü³£Ñ¹¡£´ËºóÔÙÔÚÕý³£¿ÕÆøÌõ¼þÏÂÎ¹Ñø5Ìì¡£

¡¾Ä£×ÓÌØµã¡¿£º

¾­ÓÉ5ÌìµÄÑõÓÕµ¼£¬²¢ÔÚÕý³£¿ÕÆøÌõ¼þÏÂËÇÑø5Ììºó£¬C57BL/6JСÊó·ºÆðÁËÏÔ×ŵÄѪ¹ÜÂÎËõ»òÕßÀ©ÕÅ¡¢ÓØÇú¡¢ÂþÑÜÏ£º±£¬²¿·ÖѪ¹Ü·ºÆð˨Èû£¬¿É¼ûÏÔ×ŵÄÎÞ¹à×¢Çø£¬Ö÷Òª¼¯ÖÐÓÚÊÓÍøÄ¤µÄÖÐÑ벿£¬Öܱ߲¿ÓÐÐÂÉúѪ¹Ü»òÉ¢ÔڵijöѪ±£´æ£¨Í¼12-4)¡£³öÉúºó17Ì죬ÑõÓÕµ¼Ð¡ÊóÓдó×ÚµÄѪ¹ÜÄÚÆ¤Ï¸°ûÍ»ÆÆÊÓÍøÄ¤ÄÚ½çĤ£¬ÓеÄÉõÖÁÐγÉѪ¹ÜÍøµÖ´ï²£Á§Ì壬¶øÔÚ³öÉúºó17ÌìµÄÕý³£Ð¡ÊóµÄÊÓÍøÄ¤×éÖ¯ÇÐÆ¬ÉÏ£¬ÏÕЩδÊÓ²ìµ½Í»ÆÆÄÚ½çĤµÄѪ¹ÜÄÚÆ¤Ï¸°ûºË¡£ÑõÓÕµ¼Ð¡ÊóÄÚ²ãÊÓÍøÄ¤µÄ¿¹VEGFÃâÒß×éÖ¯»¯Ñ§È¾É«ÔöÇ¿¡£

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú 

ͼ12-4 ÑõÓÕµ¼Ð¡ÊóÊÓÍøÄ¤ÐÂÉúѪ¹Ü

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

ÑõÓÕµ¼ÊÓÍøÄ¤ÐÂÉúѪ¹Ü¿ÉÄ£ÄâÔç²ú¶ù¹ýÔç̻¶ÓÚÕý³£Ñõ·ÖѹÇéÐΣ¬ÒýÆðÔç²ú¶ùÊÓÍøÄ¤¼²²¡µÄ²¡Àý£¬¿ÉΪÑо¿Ôç²ú¶ùÊÓÍøÄ¤¼²²¡µÄÕïÖÎÌṩʵÑé»ù´¡¡£ÔìÄ£Àú³ÌÖУ¬Îª°ü¹ÜСÊó³ö²ÕºóµÄ´æ»îÂÊ£¬¿ÉÌìÌì·­¿ª´óÆøÌåÁ÷Èë¿ÚºÍÁ÷³ö¿Ú³ä·Ö»»ÆøÈÃʵÑ鶯Îï´ú뱬·¢µÄÓж¾Óк¦ÆøÌå³ä·ÖÇãÔþ£¬Ò²ÎªÁËʹˮÕôÆøÄܹ»ÇãÔþ£¬´ËºóÔÙÖØÐµ÷ÀíÑõÁ÷Á¿£¬Ê¹Æä¼á³ÖÔÚʵÑéŨ¶ÈÌõ¼þϼ´¿É¡£ÌØÊâÊÇÏÄÈÕ£¬Òª¾­³£Í¸·ç¡£ÊµÑéʱ´úÈôÓÐĸÊóéæÃü£¬Ôò¿ª²ÕÓñ¸ÓÃĸÊóÈ¡´ú²¸È飬¿ÉÓÃÌæ»»Ä¸ÊóµÄµæÁϳä·ÖÁýÕÖºÍͿĨ×ÐÊ󣬱ÜÃâʳ×ÐÊó»òÕß²»²¸ÈéÕ÷ÏóµÄ±¬·¢¡£

 

²Î¿¼ÎÄÏ×£º

1.ÍõÓ¦Àû£¬»ÝÑÓÄ꣮ÌÇÄò²¡ÊÓÍøÄ¤²¡±ä»»ÎïÄ£×ÓÑ¡ÔñµÄ×¢ÖØÊÂÏÖлªÑÛ¿ÆÔÓÖ¾£¬2012,48 (7):587-590

2.Baehr W, Frederick JM. Naturally occurring animal models with outer retina phenotypes. Vis Res,2009,49: 2636-2652

3.Bourne MC, Campbell DA, Tansley K. Hereditary degeneration of rat retina. Br J Ophthalmol, 1938,22(10): 613-623

4.Bundey S,Crews SJ. A study of retinitis pigrnentosa in the city of Birmingham-I. J Med Genet, 1984,21(6):417-420

5.Chang B, Heckenlively IB,Bayley PR.et a.I. The nob2 mouse, a null mutation in Cacnalf: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Vis Neurosci, 2006, 23 (1): 11-24

6.Criswell MH,Ciulla TA,Hill TE,et al. The squirrelmonkey: characterization of a new-world primate model of xperimental choroidal neovascularizalion and comparison with the macaque. Invest Ophthalmol Vis Sci,2004, 45 (2): 625-634

7.Gu Y, Wang L,Zhou J,et al. A naturally-occurring mutation in CacnaIf in a rat model of congenital stationary night blindness. Mo! Vis,2008, 14(1):20-28

8.Lue CL. Rod cell activity in retinal degenerative rats. J Formos Med Assoc, 1994,93(7):605-610

9.Pinkert CA. Transgenic animal technology. New York: Academic Press, 1994

10.Sato H, Suzuki T, Ikeda K, et aL A monogenic dominant mutation in Rom l generated by N-ethyl-N-nitrosourea mutagenesis causes retinal degeneration in mice. Mol Vis,2010, 16:378-391

11.Williams TP, Howell WL. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci, 1983, 24 (3):285-287

12.Won J, Shi LY, Hicks W, et al. Mouse model resources for vision research. J Ophthalmol,2011,2011:391384

13.Xie B,Nakanishi S,Guo Q,et al. A novel middle­wavelength opsin (M-opsin) null-mutation in the retinal cone dysfunction ral. Exp Eye Res,2010,91(1):26-33

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > ÑõÓÕµ¼ÊÓÍøÄ¤ÐÂÉúѪ¹Ü
ÑõÓÕµ¼ÊÓÍøÄ¤ÐÂÉúѪ¹Ü

ǰÑÔ

ÄêËêÏà¹ØÐԻư߱äÐÔ(age related macular dege­neralion, AMD)ÊÇ65ËêÒÔÉÏÍíÄêÈËÖÂäµÄÖ÷ÒªÔµ¹ÊÔ­ÓÉ¡£AMD·ÖΪÎÞÐÂÉúѪ¹ÜÌìÉúµÄ¸ÉÐÔÒÔ¼°ÐÂÉúѪ¹ÜÌìÉúµÄʪÐÔÌåÏÖ¡£ÊªÐÔAMD»¼Õß±¬·¢CNVÊǵ¼ÖÂÊÓÁ¦ËðʧµÄ×î³£¼ûÒòËØ¡£±¾Õ½«ÏÈÈÝCNVµÄÔìÄ£ÒªÁì¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

ÑõÓÕµ¼ÊÓÍøÄ¤ÐÂÉúѪ¹Ü£¬²¡ÀíÐÔµÄÐÂÉúѪ¹ÜÐγɰéÓдÓÊÓÍøÄ¤ÅÀÐе½²£Á§ÌåÒì³£µÄѪ¹ÜÑ¿¡£ÕâÖÖÐÂÉúѪ¹ÜÑ¿µ¼ÖÂÐí¶à²¢·¢Ö¢£¬ÈçѪ½¬ÉøÂ©¡¢³öѪ£¬²¢ÔÚijЩÇéÐÎÏ£¬ÒýÆðÇ£À­ÐÔÊÓÍøÄ¤ÍÑÀë»òÖÂä¡£ÔÚ¸ßÑõ̻¶µÄµÚÒ»¸ö½×¶Î£¨³öÉúºó7~12Ì죩£¬ÊÓÍøÄ¤Ñª¹ÜËõ¶ÌÒÔµ÷ÀíÊÓÍøÄ¤ÖеÄÑõ·Öѹ£¬Í¬Ê±Î»ÓÚÖÐÐÄÊÓÍøÄ¤ÇøµÄ²»¿ÉÊìëϸѪ¹ÜÍË»¯µ¼ÖÂÖÐÐÄÇøÑª¹Ü±ÕÈû¡£ÓÉÓÚ¸ßÑõ̻¶ºÍÐÄÀíÐԵıÊֱѪ¹ÜÑ¿´Ódz²ãëϸѪ¹ÜÍøÏòÉî²ãÉú³¤µÄʱÏàÖØµþ£¬´Ó¶øµ¼ÖÂÊÓÍøÄ¤Éî²ãëϸѪ¹ÜÍøÐγÉÏÔ×ŵÄÑÓ³Ù¡£µÚ¶þ¸ö½×¶Î£¬ÔÚ³öÉúºó12Ìì»Øµ½Õý³£¿ÕÆøÇéÐÎÖÐÖ®ºó£¬Ñª¹Ü±ÕÈûÇø×îÏÈȱÑõ£¬Ð¡ÊóµÄÊÓÍøÄ¤Ñª¹Ü±ÕÈûÇøÎÞѪ¹ÜºÍ²¡ÀíÐÔÐÂÉúѪ¹ÜµÄÌìÉú¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

½«1ÖÜСÊóÓëËüÃǵÄĸÊóÖÃÓÚÑõŨ¶ÈΪ75£¥±2£¥µÄ¶¯ÎïÑõ²ÕÖÐÎ¹Ñø5Ìì¡£Ñõ²ÕÄÚÑõÁ÷Á¿¿ØÖÆÔÚ0.5~0.6L/min£¬ÅÅÆøÁ÷Á¿¾Þϸ¿É×ÔÐе÷Àí£¬°ü¹ÜÑõÆøÑ­»·Á÷¶¯£¬²¢ÇÒŨ¶ÈÎȹÌÔÚ75£¥×óÓÒ£¬±È¼°Ñõ²ÕÖÐÑõÆøÅ¨¶ÈÎȹ̺ó£¬Ã¿¸ô4СʱÓÃÊý×Ö²âÑõÒǼà²âÑõ²ÕÄÚÑõÆøÅ¨¶È£¬°ü¹ÜÆøÌåµÄÁ÷ÈëºÍÁ÷³öƽºâ¡£Ñõ²ÕÄÚѹÁ¦Ò»¶¨Òª¼á³ÖΪ³£Ñ¹»òÕß¿¿½ü³£Ñ¹¡£´ËºóÔÙÔÚÕý³£¿ÕÆøÌõ¼þÏÂÎ¹Ñø5Ìì¡£

¡¾Ä£×ÓÌØµã¡¿£º

¾­ÓÉ5ÌìµÄÑõÓÕµ¼£¬²¢ÔÚÕý³£¿ÕÆøÌõ¼þÏÂËÇÑø5Ììºó£¬C57BL/6JСÊó·ºÆðÁËÏÔ×ŵÄѪ¹ÜÂÎËõ»òÕßÀ©ÕÅ¡¢ÓØÇú¡¢ÂþÑÜÏ£º±£¬²¿·ÖѪ¹Ü·ºÆð˨Èû£¬¿É¼ûÏÔ×ŵÄÎÞ¹à×¢Çø£¬Ö÷Òª¼¯ÖÐÓÚÊÓÍøÄ¤µÄÖÐÑ벿£¬Öܱ߲¿ÓÐÐÂÉúѪ¹Ü»òÉ¢ÔڵijöѪ±£´æ£¨Í¼12-4)¡£³öÉúºó17Ì죬ÑõÓÕµ¼Ð¡ÊóÓдó×ÚµÄѪ¹ÜÄÚÆ¤Ï¸°ûÍ»ÆÆÊÓÍøÄ¤ÄÚ½çĤ£¬ÓеÄÉõÖÁÐγÉѪ¹ÜÍøµÖ´ï²£Á§Ì壬¶øÔÚ³öÉúºó17ÌìµÄÕý³£Ð¡ÊóµÄÊÓÍøÄ¤×éÖ¯ÇÐÆ¬ÉÏ£¬ÏÕЩδÊÓ²ìµ½Í»ÆÆÄÚ½çĤµÄѪ¹ÜÄÚÆ¤Ï¸°ûºË¡£ÑõÓÕµ¼Ð¡ÊóÄÚ²ãÊÓÍøÄ¤µÄ¿¹VEGFÃâÒß×éÖ¯»¯Ñ§È¾É«ÔöÇ¿¡£

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú 

ͼ12-4 ÑõÓÕµ¼Ð¡ÊóÊÓÍøÄ¤ÐÂÉúѪ¹Ü

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

ÑõÓÕµ¼ÊÓÍøÄ¤ÐÂÉúѪ¹Ü¿ÉÄ£ÄâÔç²ú¶ù¹ýÔç̻¶ÓÚÕý³£Ñõ·ÖѹÇéÐΣ¬ÒýÆðÔç²ú¶ùÊÓÍøÄ¤¼²²¡µÄ²¡Àý£¬¿ÉΪÑо¿Ôç²ú¶ùÊÓÍøÄ¤¼²²¡µÄÕïÖÎÌṩʵÑé»ù´¡¡£ÔìÄ£Àú³ÌÖУ¬Îª°ü¹ÜСÊó³ö²ÕºóµÄ´æ»îÂÊ£¬¿ÉÌìÌì·­¿ª´óÆøÌåÁ÷Èë¿ÚºÍÁ÷³ö¿Ú³ä·Ö»»ÆøÈÃʵÑ鶯Îï´ú뱬·¢µÄÓж¾Óк¦ÆøÌå³ä·ÖÇãÔþ£¬Ò²ÎªÁËʹˮÕôÆøÄܹ»ÇãÔþ£¬´ËºóÔÙÖØÐµ÷ÀíÑõÁ÷Á¿£¬Ê¹Æä¼á³ÖÔÚʵÑéŨ¶ÈÌõ¼þϼ´¿É¡£ÌØÊâÊÇÏÄÈÕ£¬Òª¾­³£Í¸·ç¡£ÊµÑéʱ´úÈôÓÐĸÊóéæÃü£¬Ôò¿ª²ÕÓñ¸ÓÃĸÊóÈ¡´ú²¸È飬¿ÉÓÃÌæ»»Ä¸ÊóµÄµæÁϳä·ÖÁýÕÖºÍͿĨ×ÐÊ󣬱ÜÃâʳ×ÐÊó»òÕß²»²¸ÈéÕ÷ÏóµÄ±¬·¢¡£

 

²Î¿¼ÎÄÏ×£º

1.ÍõÓ¦Àû£¬»ÝÑÓÄ꣮ÌÇÄò²¡ÊÓÍøÄ¤²¡±ä»»ÎïÄ£×ÓÑ¡ÔñµÄ×¢ÖØÊÂÏÖлªÑÛ¿ÆÔÓÖ¾£¬2012,48 (7):587-590

2.Baehr W, Frederick JM. Naturally occurring animal models with outer retina phenotypes. Vis Res,2009,49: 2636-2652

3.Bourne MC, Campbell DA, Tansley K. Hereditary degeneration of rat retina. Br J Ophthalmol, 1938,22(10): 613-623

4.Bundey S,Crews SJ. A study of retinitis pigrnentosa in the city of Birmingham-I. J Med Genet, 1984,21(6):417-420

5.Chang B, Heckenlively IB,Bayley PR.et a.I. The nob2 mouse, a null mutation in Cacnalf: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Vis Neurosci, 2006, 23 (1): 11-24

6.Criswell MH,Ciulla TA,Hill TE,et al. The squirrelmonkey: characterization of a new-world primate model of xperimental choroidal neovascularizalion and comparison with the macaque. Invest Ophthalmol Vis Sci,2004, 45 (2): 625-634

7.Gu Y, Wang L,Zhou J,et al. A naturally-occurring mutation in CacnaIf in a rat model of congenital stationary night blindness. Mo! Vis,2008, 14(1):20-28

8.Lue CL. Rod cell activity in retinal degenerative rats. J Formos Med Assoc, 1994,93(7):605-610

9.Pinkert CA. Transgenic animal technology. New York: Academic Press, 1994

10.Sato H, Suzuki T, Ikeda K, et aL A monogenic dominant mutation in Rom l generated by N-ethyl-N-nitrosourea mutagenesis causes retinal degeneration in mice. Mol Vis,2010, 16:378-391

11.Williams TP, Howell WL. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci, 1983, 24 (3):285-287

12.Won J, Shi LY, Hicks W, et al. Mouse model resources for vision research. J Ophthalmol,2011,2011:391384

13.Xie B,Nakanishi S,Guo Q,et al. A novel middle­wavelength opsin (M-opsin) null-mutation in the retinal cone dysfunction ral. Exp Eye Res,2010,91(1):26-33

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿